Australian Clinical Labs Ltd (AU:ACL) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Australian Clinical Labs Ltd has announced an update on its ongoing share buy-back program, revealing that it repurchased 125,000 shares on the previous day. This move brings the total number of shares bought back to 955,864, highlighting the company’s strategy to potentially enhance shareholder value.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.